PB
Panbela Therapeutics, Inc.
PBLA · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $485.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 10,520.50%
Asset turnover 0.00x
ROA 214.06%
Debt
57 /100
Moderate Current ratio 0.25x
Int. coverage 81.28x
Debt/Equity N/A
Stability
1 /100
Unstable Beta 1.88x
Profitable years 0
EPS volatility 233.84%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o PBLA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer K. Simpson
Employees
8
Headquarters
Waconia
Nadchodzące wydarzenia
13 LIS
Earnings
Upcoming earnings report